Leo van de Putte
Overview
Explore the profile of Leo van de Putte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Michou L, Cornelis F, Levesque J, Bombardieri S, Balsa A, Westhovens R, et al.
Joint Bone Spine
. 2012 Feb;
79(5):451-6.
PMID: 22341585
Objective: The CLEC12A gene codes for an immune inhibitory receptor that maps to 12p13.2. Since an increase in CLEC12A mRNA correlates with rheumatoid factor values greater than 40 IU/ml in...
2.
Dawidowicz K, Allanore Y, Guedj M, Pierlot C, Bombardieri S, Balsa A, et al.
Ann Rheum Dis
. 2010 Oct;
70(1):117-21.
PMID: 20980283
Background: Increased expression of type I IFN genes, also referred to as an IFN signature, has been detected in various autoimmune diseases including rheumatoid arthritis (RA). Interferon regulatory factors, such...
3.
Burkhardt J, Petit-Teixeira E, Teixeira V, Kirsten H, Garnier S, Ruehle S, et al.
J Rheumatol
. 2009 Sep;
36(10):2149-57.
PMID: 19723899
Objective: Rheumatoid arthritis (RA) is an inflammatory joint disease with features of an autoimmune disease with female predominance. Candidate genes located on the X-chromosome were selected for a family trio-based...
4.
Teixeira V, Pierlot C, Migliorini P, Balsa A, Westhovens R, Barrera P, et al.
Arthritis Res Ther
. 2009 Mar;
11(2):R45.
PMID: 19302705
Introduction: A candidate gene approach, in a large case-control association study in the Dutch population, has shown that a 480 kb block on chromosome 4q27 encompassing KIAA1109/Tenr/IL2/IL21 genes is associated...
5.
Jacq L, Garnier S, Dieude P, Michou L, Pierlot C, Migliorini P, et al.
Arthritis Res Ther
. 2007 Jul;
9(4):R63.
PMID: 17615072
The integrin alpha(v)beta3, whose alpha(v) subunit is encoded by the ITGAV gene, plays a key role in angiogenesis. Hyperangiogenesis is involved in rheumatoid arthritis (RA) and the ITGAV gene is...
6.
Michou L, Lasbleiz S, Rat A, Migliorini P, Balsa A, Westhovens R, et al.
Proc Natl Acad Sci U S A
. 2007 Jan;
104(5):1649-54.
PMID: 17237219
The tyrosine phosphatase PTPN22 allele 1858T has been associated with rheumatoid arthritis (RA) and other autoimmune diseases. RA is the most frequent of those multifactorial diseases. The RA association was...
7.
Hartman M, van Ede A, Severens J, Laan R, van de Putte L, van der Wilt G
J Rheumatol
. 2004 May;
31(5):902-8.
PMID: 15124248
Objective: To determine cost-effectiveness of folic or folinic acid supplementation in patients with rheumatoid arthritis (RA) who started methotrexate (MTX) treatment. Methods: An economic evaluation, performed alongside a randomized, double...
8.
Abadie E, Ethgen D, Avouac B, Bouvenot G, Branco J, Bruyere O, et al.
Osteoarthritis Cartilage
. 2004 Mar;
12(4):263-8.
PMID: 15023377
Background: Recent innovations in the pharmaceutical drug discovery environment have generated new chemical entities with the potential to become disease modifying drugs for osteoarthritis (DMOAD's). Regulatory agencies acknowledge that such...
9.
Zandbelt M, De Wilde P, Van Damme P, Hoyng C, van de Putte L, van den Hoogen F
J Rheumatol
. 2004 Jan;
31(1):96-101.
PMID: 14705226
Objective: This pilot study evaluated the effect of anti-tumor necrosis factor-a antiinflammatory treatment with etanercept (Enbrel(R)) on sicca, systemic, and histological signs in patients with primary Sjögren's syndrome (SS). Methods:...
10.
Rau R, Sander O, van Riel P, van de Putte L, Hasler F, Zaug M, et al.
J Rheumatol
. 2003 Apr;
30(4):680-90.
PMID: 12672184
Objective: To determine the optimal dose regimen for intravenous Ro 45-2081 (lenercept) in patients with rheumatoid arthritis (RA) by evaluating efficacy, safety, tolerability, and pharmacokinetic and pharmacodynamic characteristics. Methods: Adult...